Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection

We demonstrated the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicated human symptoms, including severe lung pathology and lymphopenia. Our comprehensive study revealed the key role of neutrophil-mediated lung immunopathology in...

Full description

Saved in:
Bibliographic Details
Published inJournal of virology Vol. 96; no. 9; p. e0003822
Main Authors Zheng, Xiao-Shuang, Wang, Qi, Min, Juan, Shen, Xu-Rui, Li, Qian, Zhao, Qiu-Chen, Wang, Xi, Jiang, Ren-Di, Geng, Rong, Chen, Ying, Zhu, Yan, Li, Bei, Zhang, Wei, Li, Ang, Xie, Ting-Ting, Liu, Mei-Qin, Cheng, Liang, Shi, Zheng-Li, Zhou, Peng
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 11.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We demonstrated the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicated human symptoms, including severe lung pathology and lymphopenia. Our comprehensive study revealed the key role of neutrophil-mediated lung immunopathology in SARS-CoV-2-induced severe pneumonia, which not only helped our understanding of COVID-19 but also warranted the concept of neutrophil targeting therapeutics in COVID-19 treatment. Due to the limitation of human studies with respect to individual difference or the accessibility of fresh tissue samples, how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in pathological complications in lung, the main site of infection, is still incompletely understood. Therefore, physiologically relevant animal models under realistic SARS-CoV-2 infection conditions would be helpful to our understanding of dysregulated inflammation response in lung in the context of targeted therapeutics. Here, we characterized the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicates human symptoms, including severe lung pathology and lymphopenia. We showed a reduction of lymphocyte populations and an increase of neutrophils in lung and then demonstrated the key role of neutrophil-mediated lung immunopathology in both mice and humans. Under severe conditions, neutrophils recruited by a chemokine-driven positive feedback produced elevated “fatal signature” proinflammatory genes and pathways related to neutrophil activation or releasing of granular content. In addition, we identified a new Cd177 high cluster that is undergoing respiratory burst and Stfa high cluster cells that may dampen antigen presentation upon infection. We also revealed the devastating effect of overactivated neutrophil by showing the highly enriched neutrophil extracellular traps in lung and a dampened B-cell function in either lung or spleen that may be attributed to arginine consumption by neutrophil. The current study helped our understanding of SARS-CoV-2-induced pneumonia and warranted the concept of neutrophil-targeting therapeutics in COVID-19 treatment. IMPORTANCE We demonstrated the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicated human symptoms, including severe lung pathology and lymphopenia. Our comprehensive study revealed the key role of neutrophil-mediated lung immunopathology in SARS-CoV-2-induced severe pneumonia, which not only helped our understanding of COVID-19 but also warranted the concept of neutrophil targeting therapeutics in COVID-19 treatment.
AbstractList Due to the limitation of human studies with respect to individual difference or the accessibility of fresh tissue samples, how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in pathological complications in lung, the main site of infection, is still incompletely understood. Therefore, physiologically relevant animal models under realistic SARS-CoV-2 infection conditions would be helpful to our understanding of dysregulated inflammation response in lung in the context of targeted therapeutics. Here, we characterized the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicates human symptoms, including severe lung pathology and lymphopenia. We showed a reduction of lymphocyte populations and an increase of neutrophils in lung and then demonstrated the key role of neutrophil-mediated lung immunopathology in both mice and humans. Under severe conditions, neutrophils recruited by a chemokine-driven positive feedback produced elevated "fatal signature" proinflammatory genes and pathways related to neutrophil activation or releasing of granular content. In addition, we identified a new Cd177 cluster that is undergoing respiratory burst and Stfa cluster cells that may dampen antigen presentation upon infection. We also revealed the devastating effect of overactivated neutrophil by showing the highly enriched neutrophil extracellular traps in lung and a dampened B-cell function in either lung or spleen that may be attributed to arginine consumption by neutrophil. The current study helped our understanding of SARS-CoV-2-induced pneumonia and warranted the concept of neutrophil-targeting therapeutics in COVID-19 treatment. We demonstrated the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicated human symptoms, including severe lung pathology and lymphopenia. Our comprehensive study revealed the key role of neutrophil-mediated lung immunopathology in SARS-CoV-2-induced severe pneumonia, which not only helped our understanding of COVID-19 but also warranted the concept of neutrophil targeting therapeutics in COVID-19 treatment.
Due to the limitation of human studies with respect to individual difference or the accessibility of fresh tissue samples, how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in pathological complications in lung, the main site of infection, is still incompletely understood. Therefore, physiologically relevant animal models under realistic SARS-CoV-2 infection conditions would be helpful to our understanding of dysregulated inflammation response in lung in the context of targeted therapeutics. Here, we characterized the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicates human symptoms, including severe lung pathology and lymphopenia. We showed a reduction of lymphocyte populations and an increase of neutrophils in lung and then demonstrated the key role of neutrophil-mediated lung immunopathology in both mice and humans. Under severe conditions, neutrophils recruited by a chemokine-driven positive feedback produced elevated “fatal signature” proinflammatory genes and pathways related to neutrophil activation or releasing of granular content. In addition, we identified a new Cd177 high cluster that is undergoing respiratory burst and Stfa high cluster cells that may dampen antigen presentation upon infection. We also revealed the devastating effect of overactivated neutrophil by showing the highly enriched neutrophil extracellular traps in lung and a dampened B-cell function in either lung or spleen that may be attributed to arginine consumption by neutrophil. The current study helped our understanding of SARS-CoV-2-induced pneumonia and warranted the concept of neutrophil-targeting therapeutics in COVID-19 treatment. IMPORTANCE We demonstrated the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicated human symptoms, including severe lung pathology and lymphopenia. Our comprehensive study revealed the key role of neutrophil-mediated lung immunopathology in SARS-CoV-2-induced severe pneumonia, which not only helped our understanding of COVID-19 but also warranted the concept of neutrophil targeting therapeutics in COVID-19 treatment.
We demonstrated the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicated human symptoms, including severe lung pathology and lymphopenia. Our comprehensive study revealed the key role of neutrophil-mediated lung immunopathology in SARS-CoV-2-induced severe pneumonia, which not only helped our understanding of COVID-19 but also warranted the concept of neutrophil targeting therapeutics in COVID-19 treatment. Due to the limitation of human studies with respect to individual difference or the accessibility of fresh tissue samples, how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in pathological complications in lung, the main site of infection, is still incompletely understood. Therefore, physiologically relevant animal models under realistic SARS-CoV-2 infection conditions would be helpful to our understanding of dysregulated inflammation response in lung in the context of targeted therapeutics. Here, we characterized the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicates human symptoms, including severe lung pathology and lymphopenia. We showed a reduction of lymphocyte populations and an increase of neutrophils in lung and then demonstrated the key role of neutrophil-mediated lung immunopathology in both mice and humans. Under severe conditions, neutrophils recruited by a chemokine-driven positive feedback produced elevated “fatal signature” proinflammatory genes and pathways related to neutrophil activation or releasing of granular content. In addition, we identified a new Cd177 high cluster that is undergoing respiratory burst and Stfa high cluster cells that may dampen antigen presentation upon infection. We also revealed the devastating effect of overactivated neutrophil by showing the highly enriched neutrophil extracellular traps in lung and a dampened B-cell function in either lung or spleen that may be attributed to arginine consumption by neutrophil. The current study helped our understanding of SARS-CoV-2-induced pneumonia and warranted the concept of neutrophil-targeting therapeutics in COVID-19 treatment. IMPORTANCE We demonstrated the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicated human symptoms, including severe lung pathology and lymphopenia. Our comprehensive study revealed the key role of neutrophil-mediated lung immunopathology in SARS-CoV-2-induced severe pneumonia, which not only helped our understanding of COVID-19 but also warranted the concept of neutrophil targeting therapeutics in COVID-19 treatment.
Due to the limitation of human studies with respect to individual difference or the accessibility of fresh tissue samples, how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in pathological complications in lung, the main site of infection, is still incompletely understood. Therefore, physiologically relevant animal models under realistic SARS-CoV-2 infection conditions would be helpful to our understanding of dysregulated inflammation response in lung in the context of targeted therapeutics. Here, we characterized the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicates human symptoms, including severe lung pathology and lymphopenia. We showed a reduction of lymphocyte populations and an increase of neutrophils in lung and then demonstrated the key role of neutrophil-mediated lung immunopathology in both mice and humans. Under severe conditions, neutrophils recruited by a chemokine-driven positive feedback produced elevated “fatal signature” proinflammatory genes and pathways related to neutrophil activation or releasing of granular content. In addition, we identified a new Cd177high cluster that is undergoing respiratory burst and Stfahigh cluster cells that may dampen antigen presentation upon infection. We also revealed the devastating effect of overactivated neutrophil by showing the highly enriched neutrophil extracellular traps in lung and a dampened B-cell function in either lung or spleen that may be attributed to arginine consumption by neutrophil. The current study helped our understanding of SARS-CoV-2-induced pneumonia and warranted the concept of neutrophil-targeting therapeutics in COVID-19 treatment. IMPORTANCE We demonstrated the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicated human symptoms, including severe lung pathology and lymphopenia. Our comprehensive study revealed the key role of neutrophil-mediated lung immunopathology in SARS-CoV-2-induced severe pneumonia, which not only helped our understanding of COVID-19 but also warranted the concept of neutrophil targeting therapeutics in COVID-19 treatment.
Due to the limitation of human studies with respect to individual difference or the accessibility of fresh tissue samples, how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in pathological complications in lung, the main site of infection, is still incompletely understood. Therefore, physiologically relevant animal models under realistic SARS-CoV-2 infection conditions would be helpful to our understanding of dysregulated inflammation response in lung in the context of targeted therapeutics. Here, we characterized the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicates human symptoms, including severe lung pathology and lymphopenia. We showed a reduction of lymphocyte populations and an increase of neutrophils in lung and then demonstrated the key role of neutrophil-mediated lung immunopathology in both mice and humans. Under severe conditions, neutrophils recruited by a chemokine-driven positive feedback produced elevated "fatal signature" proinflammatory genes and pathways related to neutrophil activation or releasing of granular content. In addition, we identified a new Cd177high cluster that is undergoing respiratory burst and Stfahigh cluster cells that may dampen antigen presentation upon infection. We also revealed the devastating effect of overactivated neutrophil by showing the highly enriched neutrophil extracellular traps in lung and a dampened B-cell function in either lung or spleen that may be attributed to arginine consumption by neutrophil. The current study helped our understanding of SARS-CoV-2-induced pneumonia and warranted the concept of neutrophil-targeting therapeutics in COVID-19 treatment. IMPORTANCE We demonstrated the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicated human symptoms, including severe lung pathology and lymphopenia. Our comprehensive study revealed the key role of neutrophil-mediated lung immunopathology in SARS-CoV-2-induced severe pneumonia, which not only helped our understanding of COVID-19 but also warranted the concept of neutrophil targeting therapeutics in COVID-19 treatment.Due to the limitation of human studies with respect to individual difference or the accessibility of fresh tissue samples, how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in pathological complications in lung, the main site of infection, is still incompletely understood. Therefore, physiologically relevant animal models under realistic SARS-CoV-2 infection conditions would be helpful to our understanding of dysregulated inflammation response in lung in the context of targeted therapeutics. Here, we characterized the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicates human symptoms, including severe lung pathology and lymphopenia. We showed a reduction of lymphocyte populations and an increase of neutrophils in lung and then demonstrated the key role of neutrophil-mediated lung immunopathology in both mice and humans. Under severe conditions, neutrophils recruited by a chemokine-driven positive feedback produced elevated "fatal signature" proinflammatory genes and pathways related to neutrophil activation or releasing of granular content. In addition, we identified a new Cd177high cluster that is undergoing respiratory burst and Stfahigh cluster cells that may dampen antigen presentation upon infection. We also revealed the devastating effect of overactivated neutrophil by showing the highly enriched neutrophil extracellular traps in lung and a dampened B-cell function in either lung or spleen that may be attributed to arginine consumption by neutrophil. The current study helped our understanding of SARS-CoV-2-induced pneumonia and warranted the concept of neutrophil-targeting therapeutics in COVID-19 treatment. IMPORTANCE We demonstrated the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicated human symptoms, including severe lung pathology and lymphopenia. Our comprehensive study revealed the key role of neutrophil-mediated lung immunopathology in SARS-CoV-2-induced severe pneumonia, which not only helped our understanding of COVID-19 but also warranted the concept of neutrophil targeting therapeutics in COVID-19 treatment.
Author Jiang, Ren-Di
Geng, Rong
Shen, Xu-Rui
Zhao, Qiu-Chen
Zhang, Wei
Min, Juan
Chen, Ying
Zheng, Xiao-Shuang
Li, Ang
Shi, Zheng-Li
Zhou, Peng
Li, Qian
Liu, Mei-Qin
Xie, Ting-Ting
Li, Bei
Wang, Qi
Cheng, Liang
Wang, Xi
Zhu, Yan
Author_xml – sequence: 1
  givenname: Xiao-Shuang
  surname: Zheng
  fullname: Zheng, Xiao-Shuang
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 2
  givenname: Qi
  surname: Wang
  fullname: Wang, Qi
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 3
  givenname: Juan
  surname: Min
  fullname: Min, Juan
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
– sequence: 4
  givenname: Xu-Rui
  surname: Shen
  fullname: Shen, Xu-Rui
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 5
  givenname: Qian
  surname: Li
  fullname: Li, Qian
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 6
  givenname: Qiu-Chen
  surname: Zhao
  fullname: Zhao, Qiu-Chen
  organization: Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, China
– sequence: 7
  givenname: Xi
  surname: Wang
  fullname: Wang, Xi
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 8
  givenname: Ren-Di
  surname: Jiang
  fullname: Jiang, Ren-Di
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 9
  givenname: Rong
  surname: Geng
  fullname: Geng, Rong
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 10
  givenname: Ying
  surname: Chen
  fullname: Chen, Ying
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 11
  givenname: Yan
  surname: Zhu
  fullname: Zhu, Yan
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
– sequence: 12
  givenname: Bei
  surname: Li
  fullname: Li, Bei
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
– sequence: 13
  givenname: Wei
  surname: Zhang
  fullname: Zhang, Wei
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
– sequence: 14
  givenname: Ang
  surname: Li
  fullname: Li, Ang
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 15
  givenname: Ting-Ting
  surname: Xie
  fullname: Xie, Ting-Ting
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 16
  givenname: Mei-Qin
  surname: Liu
  fullname: Liu, Mei-Qin
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 17
  givenname: Liang
  surname: Cheng
  fullname: Cheng, Liang
  organization: Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, China
– sequence: 18
  givenname: Zheng-Li
  orcidid: 0000-0001-8089-163X
  surname: Shi
  fullname: Shi, Zheng-Li
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
– sequence: 19
  givenname: Peng
  orcidid: 0000-0001-9863-4201
  surname: Zhou
  fullname: Zhou, Peng
  organization: CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35420442$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtvEzEURi1URNPCjjXyEqS6-DnxbJCqiEdEACkBxM5yZu4kjjz2MJ6JlH9fp2kRIFh5cc89-ny_C3QWYgCEnjN6zRjXr3d7d00pFZpw_ghNGC01UYrJMzShlHOihP5xji5S2lHKpCzkE3QulORUSj5Bh5ULGw9kBt7jhQ11qmwHODZ4MYZNwkvYg_UJf4QDXkZ_N_kM49DHbus8-QS1swPUeN62Y4idHbbRx80B12OfxXgBw9Z6vLpZrsgsficcz0MD1eBieIoeN9kMz-7fS_Tt3duvsw9k8eX9fHazIFYyPRCmm2khp7VUom6g4FJYRbWFogZdaAFN1YCWYl3BWum6AKmmnIGySiiWMRCX6M3J243rFuoKwtBbb7retbY_mGid-XMS3NZs4t6UtBS0LLPg5b2gjz9HSINpXaryvWyAOCbDC0W5kkwd0Vcn1KaWm10c-5C_Zhg1x6pMrsrcVWU4z-yL33P9CvTQTQb4Caj6mFIPjancYI-nyzGd_5_16q-lB-8_8VuE5rII
CitedBy_id crossref_primary_10_1182_bloodadvances_2022008834
crossref_primary_10_1128_mbio_02562_24
crossref_primary_10_1172_jci_insight_181686
crossref_primary_10_3389_fimmu_2022_1089064
crossref_primary_10_1016_j_jtos_2025_02_010
crossref_primary_10_1002_eji_202250332
crossref_primary_10_1007_s11239_024_03028_4
crossref_primary_10_14348_molcells_2022_0089
crossref_primary_10_3389_fimmu_2023_1296580
Cites_doi 10.1007/s10875-020-00920-5
10.1182/blood.v100.1.268
10.1038/s41586-020-2012-7
10.1093/bioinformatics/btaa1011
10.1016/j.isci.2021.102711
10.1038/s41577-020-0407-1
10.1084/jem.20201012
10.1016/j.febslet.2006.06.076
10.1186/s13054-020-03007-0
10.1016/j.immuni.2020.11.017
10.1183/13993003.02441-2018
10.1016/j.cell.2019.05.031
10.1038/s41591-020-0901-9
10.1001/jama.2020.2648
10.1089/omi.2011.0118
10.1038/s41591-021-01283-z
10.1016/S2213-2600(13)70053-5
10.1038/s41422-020-00455-9
10.1038/s41392-021-00749-3
10.1038/s41586-020-03148-w
10.1016/j.cell.2020.08.002
10.1038/s41577-020-00470-2
10.1016/j.cell.2013.06.013
10.1016/S2666-5247(20)30115-4
10.1084/jem.20201129
10.1038/s41587-020-0602-4
10.1016/S2666-5247(20)30144-0
10.1126/scitranslmed.abe8146
10.1038/s41467-019-09234-6
10.1016/j.cell.2021.01.004
10.1186/s12974-017-0944-0
10.1164/rccm.202008-3265OC
10.1016/j.cell.2020.05.027
10.1084/jem.20201342
10.1111/omi.12252
10.1038/s41586-021-03234-7
10.1056/NEJMoa2021436
ContentType Journal Article
Copyright Copyright © 2022 Zheng et al.
Copyright © 2022 Zheng et al. 2022 Zheng et al.
Copyright_xml – notice: Copyright © 2022 Zheng et al.
– notice: Copyright © 2022 Zheng et al. 2022 Zheng et al.
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1128/jvi.00038-22
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1098-5514
Editor Gallagher, Tom
Editor_xml – sequence: 1
  givenname: Tom
  surname: Gallagher
  fullname: Gallagher, Tom
ExternalDocumentID PMC9093099
00038-22
35420442
10_1128_jvi_00038_22
Genre Journal Article
GrantInformation_xml – fundername: Strategic Priority Research Program of the CAS
  grantid: XDB29010204
– fundername: National Natural Science Foundation of China (NSFC)
  grantid: 81772199
– fundername: National Natural Science Foundation of China (NSFC)
  grantid: 82041013
– fundername: National Natural Science Foundation of China (NSFC)
  grantid: 81822028
– fundername: National Natural Science Foundation of China (NSFC)
  grantid: 82041013
  funderid: https://doi.org/10.13039/501100001809
– fundername: National Natural Science Foundation of China (NSFC)
  grantid: 81822028
  funderid: https://doi.org/10.13039/501100001809
– fundername: National Natural Science Foundation of China (NSFC)
  grantid: 81772199
  funderid: https://doi.org/10.13039/501100001809
– fundername: ;
  grantid: 82041013
– fundername: ;
  grantid: 81772199
– fundername: ;
  grantid: XDB29010204
– fundername: ;
  grantid: 81822028
GroupedDBID ---
-~X
0R~
18M
29L
2WC
39C
4.4
53G
5GY
5RE
5VS
85S
AAFWJ
AAGFI
AAYXX
ABPPZ
ACGFO
ACNCT
ADBBV
AENEX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
E3Z
EBS
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
N9A
O9-
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
W2D
W8F
WH7
WOQ
YQT
~02
~KM
NPM
-
02
0R
ABFLS
ABPTK
ADACO
BXI
HZ
KM
RHF
UCJ
X
ZA5
7X8
5PM
ID FETCH-LOGICAL-a418t-18f7647d453dfe6243a508ae6de8683efcfe843bceb58d6e45721e5a53518aee3
ISSN 0022-538X
1098-5514
IngestDate Thu Aug 21 13:55:40 EDT 2025
Fri Jul 11 00:17:51 EDT 2025
Thu May 12 01:55:09 EDT 2022
Thu Apr 03 07:00:12 EDT 2025
Tue Jul 01 01:32:40 EDT 2025
Thu Apr 24 22:50:31 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords COVID-19
single-cell RNA sequencing
SARS-CoV-2
neutrophil
lung pathology
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a418t-18f7647d453dfe6243a508ae6de8683efcfe843bceb58d6e45721e5a53518aee3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Xiao-Shuang Zheng, Qi Wang, and Juan Min contributed equally to this article. Author order was determined by drawing straws.
The authors declare no conflict of interest.
ORCID 0000-0001-9863-4201
0000-0001-8089-163X
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC9093099
PMID 35420442
PQID 2650254159
PQPubID 23479
PageCount 18
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9093099
proquest_miscellaneous_2650254159
asm2_journals_10_1128_jvi_00038_22
pubmed_primary_35420442
crossref_citationtrail_10_1128_jvi_00038_22
crossref_primary_10_1128_jvi_00038_22
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-05-11
PublicationDateYYYYMMDD 2022-05-11
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-11
  day: 11
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of virology
PublicationTitleAbbrev J Virol
PublicationTitleAlternate J Virol
PublicationYear 2022
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_3_17_2
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_18_2
e_1_3_3_13_2
e_1_3_3_36_2
e_1_3_3_12_2
e_1_3_3_37_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_32_2
e_1_3_3_33_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_3_2
e_1_3_3_21_2
Zhou, P, Yang, X-L, Wang, X-G, Hu, B, Zhang, L, Zhang, W, Si, H-R, Zhu, Y, Li, B, Huang, C-L, Chen, H-D, Chen, J, Luo, Y, Guo, H, Jiang, R-D, Liu, M-Q, Chen, Y, Shen, X-R, Wang, X, Zheng, X-S, Zhao, K, Chen, Q-J, Deng, F, Liu, L-L, Yan, B, Zhan, F-X, Wang, Y-Y, Xiao, G-F, Shi, Z-L (B1) 2020; 579
Ma, A, Cheng, J, Yang, J, Dong, M, Liao, X, Kang, Y (B26) 2020; 24
Wu, Z, McGoogan, JM (B2) 2020; 323
Chua, RL, Lukassen, S, Trump, S, Hennig, BP, Wendisch, D, Pott, F, Debnath, O, Thürmann, L, Kurth, F, Völker, MT, Kazmierski, J, Timmermann, B, Twardziok, S, Schneider, S, Machleidt, F, Müller-Redetzky, H, Maier, M, Krannich, A, Schmidt, S, Balzer, F, Liebig, J, Loske, J, Suttorp, N, Eils, J, Ishaque, N, Liebert, UG, von Kalle, C, Hocke, A, Witzenrath, M, Goffinet, C, Drosten, C, Laudi, S, Lehmann, I, Conrad, C, Sander, L-E, Eils, R (B4) 2020; 38
Jing, Y, Luo, L, Chen, Y, Westerberg, LS, Zhou, P, Xu, Z, Herrada, AA, Park, C-S, Kubo, M, Mei, H, Hu, Y, Lee, PP-W, Zheng, B, Sui, Z, Xiao, W, Gong, Q, Lu, Z, Liu, C (B24) 2021; 6
Laforge, M, Elbim, C, Frère, C, Hémadi, M, Massaad, C, Nuss, P, Benoliel, J-J, Becker, C (B27) 2020; 20
(B8) 2021; 384
Zhou, Y, Zhou, B, Pache, L, Chang, M, Khodabakhshi, AH, Tanaseichuk, O, Benner, C, Chanda, SK (B33) 2019; 10
Stuart, T, Butler, A, Hoffman, P, Hafemeister, C, Papalexi, E, Mauck, WM, Hao, Y, Stoeckius, M, Smibert, P, Satija, R (B35) 2019; 177
Canonne-Hergaux, F, Calafat, J, Richer, E, Cellier, M, Grinstein, S, Borregaard, N, Gros, P (B18) 2002; 100
Morse, C, Tabib, T, Sembrat, J, Buschur, KL, Bittar, HT, Valenzi, E, Jiang, Y, Kass, DJ, Gibson, K, Chen, W, Mora, A, Benos, PV, Rojas, M, Lafyatis, R (B34) 2019; 54
Radermecker, C (B22) 2020; 217
Muley, MM, Krustev, E, Reid, AR, McDougall, JJ (B19) 2017; 14
Nie, X, Qian, L, Sun, R, Huang, B, Dong, X, Xiao, Q, Zhang, Q, Lu, T, Yue, L, Chen, S, Li, X, Sun, Y, Li, L, Xu, L, Li, Y, Yang, M, Xue, Z, Liang, S, Ding, X, Yuan, C, Peng, L, Liu, W, Yi, X, Lyu, M, Xiao, G, Xu, X, Ge, W, He, J, Fan, J, Wu, J, Luo, M, Chang, X, Pan, H, Cai, X, Zhou, J, Yu, J, Gao, H, Xie, M, Wang, S, Ruan, G, Chen, H, Su, H, Mei, H, Luo, D, Zhao, D, Xu, F, Li, Y, Zhu, Y, Xia, J, Hu, Y (B7) 2021; 184
Alon, R, Sportiello, M, Kozlovski, S, Kumar, A, Reilly, EC, Zarbock, A, Garbi, N, Topham, DJ (B9) 2021; 21
Yu, G, Wang, L-G, Han, Y, He, Q-Y (B36) 2012; 16
Dorward, DA, Russell, CD, Um, IH, Elshani, M, Armstrong, SD, Penrice-Randal, R, Millar, T, Lerpiniere, CEB, Tagliavini, G, Hartley, CS, Randle, NP, Gachanja, NN, Potey, PMD, Dong, X, Anderson, AM, Campbell, VL, Duguid, AJ, Al Qsous, W, BouHaidar, R, Baillie, JK, Dhaliwal, K, Wallace, WA, Bellamy, COC, Prost, S, Smith, C, Hiscox, JA, Harrison, DJ, Lucas, CD (B3) 2021; 203
Grant, RA, Morales-Nebreda, L, Markov, NS, Swaminathan, S, Querrey, M, Guzman, ER, Abbott, DA, Donnelly, HK, Donayre, A, Goldberg, IA, Klug, ZM, Borkowski, N, Lu, Z, Kihshen, H, Politanska, Y, Sichizya, L, Kang, M, Shilatifard, A, Qi, C, Lomasney, JW, Argento, AC, Kruser, JM, Malsin, ES, Pickens, CO, Smith, SB, Walter, JM, Pawlowski, AE, Schneider, D, Nannapaneni, P, Abdala-Valencia, H, Bharat, A, Gottardi, CJ, Budinger, GRS, Misharin, AV, Singer, BD, Wunderink, RG (B31) 2021; 590
Bunis, DG, Andrews, J, Fragiadakis, GK, Burt, TD, Sirota, M (B37) 2021; 36
Hanley, B, Naresh, KN, Roufosse, C, Nicholson, AG, Weir, J, Cooke, GS, Thursz, M, Manousou, P, Corbett, R, Goldin, R, Al-Sarraj, S, Abdolrasouli, A, Swann, OC, Baillon, L, Penn, R, Barclay, WS, Viola, P, Osborn, M (B14) 2020; 1
Thille, AW, Esteban, A, Fernández-Segoviano, P, Rodriguez, J-M, Aramburu, J-A, Vargas-Errázuriz, P, Martín-Pellicer, A, Lorente, JA, Frutos-Vivar, F (B32) 2013; 1
Brandes, M, Klauschen, F, Kuchen, S, Germain, RN (B13) 2013; 154
Reizine, F, Lesouhaitier, M, Gregoire, M, Pinceaux, K, Gacouin, A, Maamar, A, Painvin, B, Camus, C, Le Tulzo, Y, Tattevin, P, Revest, M, Le Bot, A, Ballerie, A, Cador-Rousseau, B, Lederlin, M, Lebouvier, T, Launey, Y, Latour, M, Verdy, C, Rossille, D, Le Gallou, S, Dulong, J, Moreau, C, Bendavid, C, Roussel, M, Cogne, M, Tarte, K, Tadié, J-M (B23) 2021; 41
Combes, AJ, Courau, T, Kuhn, NF, Hu, KH, Ray, A, Chen, WS, Chew, NW, Cleary, SJ, Kushnoor, D, Reeder, GC, Shen, A, Tsui, J, Hiam-Galvez, KJ, Muñoz-Sandoval, P, Zhu, WS, Lee, DS, Sun, Y, You, R, Magnen, M, Rodriguez, L, Im, KW, Serwas, NK, Leligdowicz, A, Zamecnik, CR, Loudermilk, RP, Wilson, MR, Ye, CJ, Fragiadakis, GK, Looney, MR, Chan, V, Ward, A, Carrillo, S, Matthay, M, Erle, DJ, Woodruff, PG, Langelier, C, Kangelaris, K, Hendrickson, CM, Calfee, C, Rao, AA, Krummel, MF (B29) 2021; 591
Mihelic, M, Teuscher, C, Turk, V, Turk, D (B16) 2006; 580
Veras, FP (B28) 2020; 217
Bernardes, JP, Mishra, N, Tran, F, Bahmer, T, Best, L, Blase, JI, Bordoni, D, Franzenburg, J, Geisen, U, Josephs-Spaulding, J, Köhler, P, Künstner, A, Rosati, E, Aschenbrenner, AC, Bacher, P, Baran, N, Boysen, T, Brandt, B, Bruse, N, Dörr, J, Dräger, A, Elke, G, Ellinghaus, D, Fischer, J, Forster, M, Franke, A, Franzenburg, S, Frey, N, Friedrichs, A, Fuß, J, Glück, A, Hamm, J, Hinrichsen, F, Hoeppner, MP, Imm, S, Junker, R, Kaiser, S, Kan, YH, Knoll, R, Lange, C, Laue, G, Lier, C, Lindner, M, Marinos, G, Markewitz, R, Nattermann, J, Noth, R, Pickkers, P, Rabe, KF, Renz, A (B30) 2020; 53
Liao, M, Liu, Y, Yuan, J, Wen, Y, Xu, G, Zhao, J, Cheng, L, Li, J, Wang, X, Wang, F, Liu, L, Amit, I, Zhang, S, Zhang, Z (B5) 2020; 26
Levy, Y (B15) 2021; 24
Silvin, A, Chapuis, N, Dunsmore, G, Goubet, A-G, Dubuisson, A, Derosa, L, Almire, C, Hénon, C, Kosmider, O, Droin, N, Rameau, P, Catelain, C, Alfaro, A, Dussiau, C, Friedrich, C, Sourdeau, E, Marin, N, Szwebel, T-A, Cantin, D, Mouthon, L, Borderie, D, Deloger, M, Bredel, D, Mouraud, S, Drubay, D, Andrieu, M, Lhonneur, A-S, Saada, V, Stoclin, A, Willekens, C, Pommeret, F, Griscelli, F, Ng, LG, Zhang, Z, Bost, P, Amit, I, Barlesi, F, Marabelle, A, Pène, F, Gachot, B, André, F, Zitvogel, L, Ginhoux, F, Fontenay, M, Solary, E (B25) 2020; 182
Speranza, E (B10) 2021; 13
Zeng, MY, Miralda, I, Armstrong, CL, Uriarte, SM, Bagaitkar, J (B20) 2019; 34
Nalbandian, A, Sehgal, K, Gupta, A, Madhavan, MV, McGroder, C, Stevens, JS, Cook, JR, Nordvig, AS, Shalev, D, Sehrawat, TS, Ahluwalia, N, Bikdeli, B, Dietz, D, Der-Nigoghossian, C, Liyanage-Don, N, Rosner, GF, Bernstein, EJ, Mohan, S, Beckley, AA, Seres, DS, Choueiri, TK, Uriel, N, Ausiello, JC, Accili, D, Freedberg, DE, Baldwin, M, Schwartz, A, Brodie, D, Garcia, CK, Elkind, MSV, Connors, JM, Bilezikian, JP, Landry, DW, Wan, EY (B21) 2021; 27
Koenig, LM (B12) 2020; 217
Schurink, B, Roos, E, Radonic, T, Barbe, E, Bouman, CSC, de Boer, HH, de Bree, GJ, Bulle, EB, Aronica, EM, Florquin, S, Fronczek, J, Heunks, LMA, de Jong, MD, Guo, L, Du Long, R, Lutter, R, Molenaar, PCG, Neefjes-Borst, EA, Niessen, HWM, van Noesel, CJM, Roelofs, JJTH, Snijder, EJ, Soer, EC, Verheij, J, Vlaar, APJ, Vos, W, van der Wel, NN, van der Wal, AC, van der Valk, P, Bugiani, M (B6) 2020; 1
Wauters, E, Van Mol, P, Garg, AD, Jansen, S, Van Herck, Y, Vanderbeke, L, Bassez, A, Boeckx, B, Malengier-Devlies, B, Timmerman, A, Van Brussel, T, Van Buyten, T, Schepers, R, Heylen, E, Dauwe, D, Dooms, C, Gunst, J, Hermans, G, Meersseman, P, Testelmans, D, Yserbyt, J, Tejpar, S, De Wever, W, Matthys, P, Neyts, J, Wauters, J, Qian, J, Lambrechts, D (B17) 2021; 31
Jiang, R-D, Liu, M-Q, Chen, Y, Shan, C, Zhou, Y-W, Shen, X-R, Li, Q, Zhang, L, Zhu, Y, Si, H-R, Wang, Q, Min, J, Wang, X, Zhang, W, Li, B, Zhang, H-J, Baric, RS, Zhou, P, Yang, X-L, Shi, Z-L (B11) 2020; 182
References_xml – ident: e_1_3_3_24_2
  doi: 10.1007/s10875-020-00920-5
– ident: e_1_3_3_19_2
  doi: 10.1182/blood.v100.1.268
– ident: e_1_3_3_2_2
  doi: 10.1038/s41586-020-2012-7
– ident: e_1_3_3_38_2
  doi: 10.1093/bioinformatics/btaa1011
– ident: e_1_3_3_16_2
  doi: 10.1016/j.isci.2021.102711
– ident: e_1_3_3_28_2
  doi: 10.1038/s41577-020-0407-1
– ident: e_1_3_3_23_2
  doi: 10.1084/jem.20201012
– ident: e_1_3_3_17_2
  doi: 10.1016/j.febslet.2006.06.076
– ident: e_1_3_3_27_2
  doi: 10.1186/s13054-020-03007-0
– ident: e_1_3_3_31_2
  doi: 10.1016/j.immuni.2020.11.017
– ident: e_1_3_3_35_2
  doi: 10.1183/13993003.02441-2018
– ident: e_1_3_3_36_2
  doi: 10.1016/j.cell.2019.05.031
– ident: e_1_3_3_6_2
  doi: 10.1038/s41591-020-0901-9
– ident: e_1_3_3_3_2
  doi: 10.1001/jama.2020.2648
– ident: e_1_3_3_37_2
  doi: 10.1089/omi.2011.0118
– ident: e_1_3_3_22_2
  doi: 10.1038/s41591-021-01283-z
– ident: e_1_3_3_33_2
  doi: 10.1016/S2213-2600(13)70053-5
– ident: e_1_3_3_18_2
  doi: 10.1038/s41422-020-00455-9
– ident: e_1_3_3_25_2
  doi: 10.1038/s41392-021-00749-3
– ident: e_1_3_3_32_2
  doi: 10.1038/s41586-020-03148-w
– ident: e_1_3_3_26_2
  doi: 10.1016/j.cell.2020.08.002
– ident: e_1_3_3_10_2
  doi: 10.1038/s41577-020-00470-2
– ident: e_1_3_3_14_2
  doi: 10.1016/j.cell.2013.06.013
– ident: e_1_3_3_15_2
  doi: 10.1016/S2666-5247(20)30115-4
– ident: e_1_3_3_29_2
  doi: 10.1084/jem.20201129
– ident: e_1_3_3_5_2
  doi: 10.1038/s41587-020-0602-4
– ident: e_1_3_3_7_2
  doi: 10.1016/S2666-5247(20)30144-0
– ident: e_1_3_3_11_2
  doi: 10.1126/scitranslmed.abe8146
– ident: e_1_3_3_34_2
  doi: 10.1038/s41467-019-09234-6
– ident: e_1_3_3_8_2
  doi: 10.1016/j.cell.2021.01.004
– ident: e_1_3_3_20_2
  doi: 10.1186/s12974-017-0944-0
– ident: e_1_3_3_4_2
  doi: 10.1164/rccm.202008-3265OC
– ident: e_1_3_3_12_2
  doi: 10.1016/j.cell.2020.05.027
– ident: e_1_3_3_13_2
  doi: 10.1084/jem.20201342
– ident: e_1_3_3_21_2
  doi: 10.1111/omi.12252
– ident: e_1_3_3_30_2
  doi: 10.1038/s41586-021-03234-7
– ident: e_1_3_3_9_2
  doi: 10.1056/NEJMoa2021436
– volume: 579
  start-page: 270
  year: 2020
  end-page: 273
  ident: B1
  article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin
  publication-title: Nature
  doi: 10.1038/s41586-020-2012-7
– volume: 177
  start-page: 1888
  year: 2019
  end-page: 1902
  ident: B35
  article-title: Comprehensive integration of single-cell data
  publication-title: Cell
  doi: 10.1016/j.cell.2019.05.031
– volume: 1
  start-page: e290
  year: 2020
  end-page: e299
  ident: B6
  article-title: Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(20)30144-0
– volume: 41
  start-page: 515
  year: 2021
  end-page: 525
  ident: B23
  article-title: SARS-CoV-2-induced ARDS associates with MDSC expansion, lymphocyte dysfunction, and arginine shortage
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-020-00920-5
– volume: 38
  start-page: 970
  year: 2020
  end-page: 979
  ident: B4
  article-title: COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis
  publication-title: Nat Biotechnol
  doi: 10.1038/s41587-020-0602-4
– volume: 34
  start-page: 27
  year: 2019
  end-page: 38
  ident: B20
  article-title: The roles of NADPH oxidase in modulating neutrophil effector responses
  publication-title: Mol Oral Microbiol
  doi: 10.1111/omi.12252
– volume: 13
  year: 2021
  ident: B10
  article-title: Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.abe8146
– volume: 24
  start-page: 102711
  year: 2021
  ident: B15
  article-title: CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
  publication-title: iScience
  doi: 10.1016/j.isci.2021.102711
– volume: 24
  start-page: 288
  year: 2020
  ident: B26
  article-title: Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
  publication-title: Crit Care
  doi: 10.1186/s13054-020-03007-0
– volume: 580
  start-page: 4195
  year: 2006
  end-page: 4199
  ident: B16
  article-title: Mouse stefins A1 and A2 (Stfa1 and Stfa2) differentiate between papain-like endo- and exopeptidases
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2006.06.076
– volume: 16
  start-page: 284
  year: 2012
  end-page: 287
  ident: B36
  article-title: clusterProfiler: an R package for comparing biological themes among gene clusters
  publication-title: Omics
  doi: 10.1089/omi.2011.0118
– volume: 154
  start-page: 197
  year: 2013
  end-page: 212
  ident: B13
  article-title: A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection
  publication-title: Cell
  doi: 10.1016/j.cell.2013.06.013
– volume: 217
  year: 2020
  ident: B12
  article-title: Blocking inflammation on the way: rationale for CXCR2 antagonists for the treatment of COVID-19
  publication-title: J Exp Med
  doi: 10.1084/jem.20201342
– volume: 384
  start-page: 693
  year: 2021
  end-page: 704
  ident: B8
  article-title: Dexamethasone in hospitalized patients with Covid-19
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2021436
– volume: 6
  start-page: 345
  year: 2021
  ident: B24
  article-title: SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00749-3
– volume: 10
  start-page: 1523
  year: 2019
  ident: B33
  article-title: Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-09234-6
– volume: 182
  start-page: 50
  year: 2020
  end-page: 58
  ident: B11
  article-title: Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2
  publication-title: Cell
  doi: 10.1016/j.cell.2020.05.027
– volume: 36
  start-page: 5535
  year: 2021
  end-page: 5536
  ident: B37
  article-title: dittoSeq: universal user-friendly single-cell and bulk RNA sequencing visualization toolkit
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btaa1011
– volume: 26
  start-page: 842
  year: 2020
  end-page: 844
  ident: B5
  article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
  publication-title: Nat Med
  doi: 10.1038/s41591-020-0901-9
– volume: 14
  start-page: 168
  year: 2017
  ident: B19
  article-title: Prophylactic inhibition of neutrophil elastase prevents the development of chronic neuropathic pain in osteoarthritic mice
  publication-title: J Neuroinflamm
  doi: 10.1186/s12974-017-0944-0
– volume: 53
  start-page: 1296
  year: 2020
  end-page: 1314
  ident: B30
  article-title: Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.11.017
– volume: 27
  start-page: 601
  year: 2021
  end-page: 615
  ident: B21
  article-title: Post-acute COVID-19 syndrome
  publication-title: Nat Med
  doi: 10.1038/s41591-021-01283-z
– volume: 20
  start-page: 515
  year: 2020
  end-page: 516
  ident: B27
  article-title: Tissue damage from neutrophil-induced oxidative stress in COVID-19
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-020-0407-1
– volume: 184
  start-page: 775
  year: 2021
  end-page: 791
  ident: B7
  article-title: Multi-organ proteomic landscape of COVID-19 autopsies
  publication-title: Cell
  doi: 10.1016/j.cell.2021.01.004
– volume: 54
  start-page: 1802441
  year: 2019
  ident: B34
  article-title: Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
  publication-title: Eur Respir J
  doi: 10.1183/13993003.02441-2018
– volume: 182
  start-page: 1401
  year: 2020
  end-page: 1418
  ident: B25
  article-title: Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19
  publication-title: Cell
  doi: 10.1016/j.cell.2020.08.002
– volume: 217
  year: 2020
  ident: B28
  article-title: SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology
  publication-title: J Exp Med
  doi: 10.1084/jem.20201129
– volume: 203
  start-page: 192
  year: 2021
  end-page: 201
  ident: B3
  article-title: Tissue-specific immunopathology in fatal COVID-19
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.202008-3265OC
– volume: 1
  start-page: 395
  year: 2013
  end-page: 401
  ident: B32
  article-title: Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(13)70053-5
– volume: 590
  start-page: 635
  year: 2021
  end-page: 641
  ident: B31
  article-title: Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
  publication-title: Nature
  doi: 10.1038/s41586-020-03148-w
– volume: 21
  start-page: 49
  year: 2021
  end-page: 64
  ident: B9
  article-title: Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-020-00470-2
– volume: 1
  start-page: e245
  year: 2020
  end-page: e253
  ident: B14
  article-title: Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(20)30115-4
– volume: 31
  start-page: 272
  year: 2021
  end-page: 290
  ident: B17
  article-title: Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages
  publication-title: Cell Res
  doi: 10.1038/s41422-020-00455-9
– volume: 217
  year: 2020
  ident: B22
  article-title: Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
  publication-title: J Exp Med
  doi: 10.1084/jem.20201012
– volume: 323
  start-page: 1239
  year: 2020
  end-page: 1242
  ident: B2
  article-title: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention
  publication-title: JAMA
  doi: 10.1001/jama.2020.2648
– volume: 100
  start-page: 268
  year: 2002
  end-page: 275
  ident: B18
  article-title: Expression and subcellular localization of NRAMP1 in human neutrophil granules
  publication-title: Blood
  doi: 10.1182/blood.v100.1.268
– volume: 591
  start-page: 124
  year: 2021
  end-page: 130
  ident: B29
  article-title: Global absence and targeting of protective immune states in severe COVID-19
  publication-title: Nature
  doi: 10.1038/s41586-021-03234-7
SSID ssj0014464
Score 2.4614177
Snippet We demonstrated the single-cell landscape in lung and spleen upon SARS-CoV-2 infection in an acute severe disease mouse model that replicated human symptoms,...
Due to the limitation of human studies with respect to individual difference or the accessibility of fresh tissue samples, how severe acute respiratory...
SourceID pubmedcentral
proquest
asm2
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0003822
SubjectTerms Pathogenesis and Immunity
Virology
Title Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection
URI https://www.ncbi.nlm.nih.gov/pubmed/35420442
https://journals.asm.org/doi/10.1128/jvi.00038-22
https://www.proquest.com/docview/2650254159
https://pubmed.ncbi.nlm.nih.gov/PMC9093099
Volume 96
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgCLSXiW86PmQQPCGPxrHT9HGqQAPGJNoNVbxETuKoQV1Srcmk8ddzZztp2q0S8BJV8TWR8vv5fHf23RHyNpF9BYYbuCX9NGHCEzFT3jBmwudYrEWmvjanfE-CozPxZSqnq6iSyS6p4oPk9415Jf-DKtwDXDFL9h-QbR8KN-A34AtXQBiuf4XxBNaduWYjjL8dY84unmYyUf8am3GO9aXG6shfYd6P3SnCE11XF-Vils_ZN9OlAwzOz5gjUmJvYluQyaUuHutqhrVCDscTNip_MA7KxJ7cKraYtJgz143S_5xpq0qmuSrZZFYrt06aCL4d-p63mLvGYPWKsBOXOzKt2bjOuxEKcG6xuKkljLZaFYuWomnWVbu2ka2j17CjQ7XZrrTZytcVPMekhV-X-YGRYutiAM_i3IDtS8H7whbu2iio3QzdJnc4-Ba8CfG4rSfwj0WTIcHDD91X7ZJ7zZ9hBVfLc75uzVxzUTZP2nZMl9P7ZM8BRA8tgR6QW7p4SO7aLqRXj8hVh0a0pREtM2poRB2NKNCIIo1w5AYa0Q0aUUsjamlEVzSiLY0ek7NPH09HR8x15GBKeGHFvDAbBGKQCumnmQ648BUY-EoHqQ6D0NdZkulQ-HGiYxmmgRZywD0tlfSlB2Laf0J2irLQzwiNvUTJQGEuHbZw8FQowXPgmRykeNSQ98gb_MCRm27LyHirPIwAkMgAEnEQet98_ihxNe2xtcp8i_S7Vnpha7lskXvdIBmBssUdNFXosl5GHPwZLsHmHfbIU4ts-6SGGT0yWMO8FcBC7usjRT4zBd2H_aEPntr-1mc-J7urifWC7FQXtX4JxnAVvzLk_QOKy7OE
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single-Cell+Landscape+of+Lungs+Reveals+Key+Role+of+Neutrophil-Mediated+Immunopathology+during+Lethal+SARS-CoV-2+Infection&rft.jtitle=Journal+of+virology&rft.au=Zheng%2C+Xiao-Shuang&rft.au=Wang%2C+Qi&rft.au=Min%2C+Juan&rft.au=Shen%2C+Xu-Rui&rft.date=2022-05-11&rft.eissn=1098-5514&rft.volume=96&rft.issue=9&rft.spage=e0003822&rft_id=info:doi/10.1128%2Fjvi.00038-22&rft_id=info%3Apmid%2F35420442&rft.externalDocID=35420442
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon